An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years

This publication has 45 references indexed in Scilit:

• Prenatal screening for chromosome abnormalities
  British Medical Bulletin, 1998
• α-Fetoprotein, free β-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome
  American Journal of Obstetrics and Gynecology, 1997
• Elevated second-trimester dimeric inhibin A levels identify Down syndrome pregnancies
  American Journal of Obstetrics and Gynecology, 1997
• Dimeric Inhibin A as a Marker for Down's Syndrome in Early Pregnancy
  New England Journal of Medicine, 1996
• Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy
  BJOG: An International Journal of Obstetrics and Gynaecology, 1996
• PRENATAL SCREENING FOR DOWN'S SYNDROME USING INHIBIN-A AS A SERUM MARKER
  Prenatal Diagnosis, 1996
• The advantages of using triple-marker screening for chromosomal abnormalities
  American Journal of Obstetrics and Gynecology, 1995
• Prenatal Screening for Down's Syndrome with Use of Maternal Serum Markers
  New England Journal of Medicine, 1992
• Maternal serum markers in screening for Down syndrome
  Clinical Genetics, 1990
• The relative effects of paternal and maternal age in mongolism
  Journal of Genetics, 1933